Fernanda De Pinho Silveira MD

Infectious Disease•Pittsburgh, PA

Professor of Medicine, University of Pittsburgh School of Medicine

Join to View Full Profile

3601 Fifth Avenue# 700Pittsburgh, PA 15213
Phone+1 412-647-7228
Fax+1 412-647-3162

Education & Training

UPMC Medical EducationFellowship, Infectious Disease, 2003 - 2005
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2000 - 2003
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1998

Certifications & Licensure

PA State Medical License 2003 - 2026
American Board of Internal Medicine Infectious Disease

Clinical Trials

Invasive Fungal Infections Surveillance Initiative Start of enrollment: 2005 Aug 01
Completed
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036) Start of enrollment: 2008 Jun 01
Completed
Not Applicable
Infectious Outcomes Following Pancreas Transplantation Start of enrollment: 2006 Apr 01
Completed
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation Start of enrollment: 2007 Jan 01
Withdrawn
Not Applicable
Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1) Start of enrollment: 2009 Oct 15
Completed
CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Start of enrollment: 2012 Oct 29
Completed
Phase 4
Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients Start of enrollment: 2015 Jul 01
Terminated
Letermovir for CMV Prevention After Lung Transplantation Start of enrollment: 2021 Dec 06
ACTIVE_NOT_RECRUITING
PHASE2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015-2020: US Hospitalized Adult Influenza Vaccine Effectiveness Netw...
Po-Han Huang, Mary Patricia Nowalk, Richard K Zimmerman, Samantha M Olson, H Keipp Talbot
Human Vaccines & Immunotherapeutics. 2025-12-01
Evolving Impact of COVID-19 on Intestinal Transplant Recipients: A Single-Center Experience.
Colin Powers, Brielle Corrente, Jennifer Joyce, William Stein, Shelly Polydor
Clinical Transplantation. 2025-01-01
Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017-2018.
Kailey Hughes Kramer, Richard K Zimmerman, Catherine L Haggerty, G K Balasubramani, Mary Patricia Nowalk
Human Vaccines & Immunotherapeutics. 2024-12-31

Press Mentions

$Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients with Cytomegalovirus (CMV) Infection (Refractory, with or Without Resistance)$
Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients with Cytomegalovirus (CMV) Infection (Refractory, with or Without Resistance)December 7th, 2021
More Organs Available for Transplant Because of Opioid EpidemicApril 18th, 2018